FIGURE 6 5.1 In vitro tests Caudatin has been found to exhibit significant growth inhibition and induces apoptosis in a variety of cancer cell lines, such as hepatocellular carcinoma cell lines (HepG2 and SMMC-7721), breast carcinoma cell line (MCF-7) and lung carcinoma cell line (A549), with IC 50 values ranging from 3.11 to 44.68 mol/L ( 5.2 In vivo tests Studies conducted in animals such as rats and mice showed that caudatin did not cause significant side effects or systemic toxicity at therapeutic doses ( 6 Conclusion This review highlights the therapeutic viability of caudatin from structural optimization, pharmacological mechanism, and clinical implications, suggesting it as a multi-facilitive scaffold for drug discovery
Maximizing Perioperative Outcome after Neoadjuvant Therapy
To address this challenge, collagen-based supplements with DPP-IV inhibitory activity have been developed to prolong the action of the two primary incretins, GLP-1 and GIP, thereby enhancing insulin secretion [155]
Low Bioavailability A Multifaceted Challenge: The poor absorption of conventional glutathione supplements is not solely due to enzymatic degradation in the gut
2014 (Int J Colorectal Dis) Type Phase II Subjects 117 bowel surgery patients (NCT00672074) Key Finding Ipamorelin 0.03 mg/kg IV twice daily was tolerated similarly to placebo
SPARC [35] and decorin [36] levels may also affect skeletal muscle metabolism via different pathways
